These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34815418)

  • 1. Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis.
    Weston KP; Gao X; Zhao J; Kim KS; Maloney SE; Gotoff J; Parikh S; Leu YC; Wu KP; Shinawi M; Steimel JP; Harrison JS; Yi JJ
    Nat Commun; 2021 Nov; 12(1):6809. PubMed ID: 34815418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.
    Geerts-Haages A; Bossuyt SNV; den Besten I; Bruggenwirth H; van der Burgt I; Yntema HG; Punt AM; Brooks A; Elgersma Y; Distel B; Valstar M
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1481. PubMed ID: 32889787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
    Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
    Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Update for UBE3A variants in Angelman syndrome.
    Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
    Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice.
    Xing L; Simon JM; Ptacek TS; Yi JJ; Loo L; Mao H; Wolter JM; McCoy ES; Paranjape SR; Taylor-Blake B; Zylka MJ
    Cell Rep; 2023 Jul; 42(7):112706. PubMed ID: 37389991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Scalable, Cell-based Method for the Functional Assessment of Ube3a Variants.
    Stelzer JA; Yi JJ
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36282706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel
    Sonzogni M; Wallaard I; Santos SS; Kingma J; du Mee D; van Woerden GM; Elgersma Y
    Mol Autism; 2018; 9():47. PubMed ID: 30220990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A.
    Yi JJ; Berrios J; Newbern JM; Snider WD; Philpot BD; Hahn KM; Zylka MJ
    Cell; 2015 Aug; 162(4):795-807. PubMed ID: 26255772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic variants in HECT E3 paralogs, HECTD4 and UBE3C, encoding ubiquitin ligases cause neurodevelopmental disorders that overlap with Angelman syndrome.
    Faqeih EA; Alghamdi MA; Almahroos MA; Alharby E; Almuntashri M; Alshangiti AM; Clément P; Calame DG; Qebibo L; Burglen L; Doco-Fenzy M; Mastrangelo M; Torella A; Manti F; Nigro V; Alban Z; Alharbi GS; Hashmi JA; Alraddadi R; Alamri R; Mitani T; Magalie B; Coban-Akdemir Z; Geckinli BB; Pehlivan D; Romito A; Karageorgou V; Martini J; Colin E; Bonneau D; Bertoli-Avella A; Lupski JR; Pastore A; Peake RWA; Dallol A; Alfadhel M; Almontashiri NAM
    Genet Med; 2023 Feb; 25(2):100323. PubMed ID: 36401616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.
    Avagliano Trezza R; Sonzogni M; Bossuyt SNV; Zampeta FI; Punt AM; van den Berg M; Rotaru DC; Koene LMC; Munshi ST; Stedehouder J; Kros JM; Williams M; Heussler H; de Vrij FMS; Mientjes EJ; van Woerden GM; Kushner SA; Distel B; Elgersma Y
    Nat Neurosci; 2019 Aug; 22(8):1235-1247. PubMed ID: 31235931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abundance and localization of human UBE3A protein isoforms.
    Sirois CL; Bloom JE; Fink JJ; Gorka D; Keller S; Germain ND; Levine ES; Chamberlain SJ
    Hum Mol Genet; 2020 Nov; 29(18):3021-3031. PubMed ID: 32833011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral Evaluation of Angelman Syndrome Mice at Older Ages.
    Dutta R; Crawley JN
    Neuroscience; 2020 Oct; 445():163-171. PubMed ID: 31730795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Nociception in Angelman Syndrome Model Mice.
    McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
    J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
    Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
    Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome.
    Jamal I; Kumar V; Vatsa N; Shekhar S; Singh BK; Sharma A; Jana NR
    Neurobiol Dis; 2017 Sep; 105():99-108. PubMed ID: 28576709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
    Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
    Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the
    Berg EL; Jami SA; Petkova SP; Berz A; Fenton TA; Lerch JP; Segal DJ; Gray JA; Ellegood J; Wöhr M; Silverman JL
    J Neurosci; 2021 Oct; 41(42):8801-8814. PubMed ID: 34475199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
    Mabb AM; Judson MC; Zylka MJ; Philpot BD
    Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.